Unlock metabolic weight loss.
Calibrate is a metabolic health company on a mission to change the way the world treats weight. We're the first outcomes-based model in obesity treatment leveraging a combination of doctor-prescribed GLP-1 medication, 1:1 video coaching, and a comprehensive curriculum—all tailored to your biology, your goals, and your life for at least 10% sustained weight loss, guaranteed.
Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company on a mission to change the way the world treats weight. In two years, Calibrate has raised more than $125 million from leading investors, including Founders Fund, Tiger Global, Optum Ventures, Forerunner Ventures, Threshold Ventures, and Redesign Health, and has published clinically-reviewed results from its One-Year Metabolic Reset that exceeded the best outcomes from clinical trials across all metabolic markers. Calibrate was recognized as a World Economic Forum Technology Pioneer in 2021 and by Fast Company’s World Changing Ideas in 2022. Prior to Calibrate, Isabelle led business operations, growth, and strategic partnerships & communications at Capsule, a technology business rebuilding the pharmacy from the inside out. Before Capsule, she worked at beloved consumer brands in London and New York. Isabelle began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania. She was selected for the Forbes 30 Under 30 list in 2015.